A 2-stage thyroid follicular carcinogenesis model in rats initiated with N-bis(2-hydroxypropyl)nitrosamine (DHPN) is widely used to detect modifying effects of chemicals on thyroid carcinogenesis. A number of goitrogens are known to strongly promote carcinogenesis, and the carcinomas often originate adjacent to the thyroid capsule and show invasive growth into the capsule or adjacent tissues. To clarify mechanisms of progression to invasive carcinomas, we sequentially evaluated histopathological and immunohistochemical characteristics of thyroids in male F344 rats treated with sulfadimethoxine (SDM, 0.1% in drinking water) for 0-10 weeks beginning 1 week after DHPN initiation (2800 mg/kg body weight, single s.c. injection). In DHPN-SDM-treated rats, multiple focal hyperplasias and adenomas developed in thyroid follicular parenchyma at weeks 4 to 6. Apart from the proliferative lesions, capsular thickening with inflammatory cell infiltration, mainly consisting of macrophages, and migration of follicular epithelium into the capsule were also observed. Focal hyperplasias/adenomas adjacent to the capsule progressively developed to invasive carcinomas at weeks 6 to 10. In thyroid parenchyma, malignant lesions were seldom observed. With SDM-treatment alone, although no neoplastic lesions were observed, capsular thickening with inflammation and epithelial migration resulted in intracapsular residual follicles. Intracapsular residual follicular cells as well as invasive and intrathyroidal carcinoma cells generally showed increased cell proliferative activity, coincidental with cytoplasmic/nuclear positivity for β-catenin. These results suggested that β-catenin activation related to capsular inflammation may play a role in development of invasive carcinomas but is insufficient for tumor formation by itself. Whether this is associated with mutations in the β-catenin gene remains to be clarified.
INTRODUCTION
The causes of many human thyroid carcinomas are unclear, but epidemiological studies show radiation is a major risk factor, at least for papillary carcinomas (Santoro et al., 2000) . Furthermore, metastatic follicular thyroid carcinomas have been reported to show a relatively high frequency in nonradiation-exposed patients in iodine deficient areas (Mishra et al., 2002) . Although no chemical has been identified as being carcinogenic to the human thyroid to date, many chemicals as well as dietary iodine deficiency have been demonstrated to induce follicular tumors in rodents (Capen, 1997) .
To evaluate risk and underlying mechanisms, rat twostage carcinogenesis models have been established (Hiasa et al., 1987; Fujimoto et al., 1992; Kim et al., 1997) . The model utilizing N-bis(2-hydroxypropyl)nitrosamine (DHPN)-initiation has already demonstrated that various types of goitrogens promote thyroid tumor development corresponding to growth stimulation by elevation of serum thyroid-stimulating hormone (TSH) levels (McClain, 1989; Mitsumori et al., 1995) . Although a proportion of carcinomas seem to be coincidently induced with focal hyperplasias and adenomas, some goitrogens are known to predominantly induce invasive carcinomas in the thyroid capsule or adjacent tissue within a short period in this model (Kitahori et al., 1984; Mitsumori et al., 1995) . The progression might occur due to formation and propagation of genetic errors due to increased cellular proliferation associated with promotion (Pitot and Dragan, 1991) , but other factors may also contribute to enhanced progression.
Sulfadimethoxine (SDM), a sulfonamide synthetic antibacterial drug (Bohni et al., 1969) , is reported to inhibit thyroid hormone synthesis resulting in thyroid growth stimulation through elevation of serum TSH. In rats initiated with DHPN, not only adenomas but also carcinomas, which frequently invade the capsule, are found at high incidences within 8-12 weeks of SDM treatment (Mitsumori et al., 1995) .
β-catenin is known as a component of cell-cell adherence junctions interacting with E-cadherin, and a close relationship of β-catenins and/or E-cadherin expression to dedifferentiation and invasiveness of cancers has been suggested for many tumors (Pötter et al., 1999) , including human thyroid carcinomas (von Wasielewski et al., 1997) and colon carcinomas (Brabletz et al., 2001) . To clarify mechanisms of the development of invasive carcinomas, here we sequentially evaluated histopathological and immunohistochemical characteristics, with a focus on β-catenin/E-cadherin expression of thyroid lesions of rats initiated with DHPN followed by SDM treatment for comparison with animals that received SDM-treatment alone.
MATERIALS AND METHODS

Animals and Treatments
A total of 65 male Fischer rats (Charles River Japan Inc., Kanagawa, Japan) at 6 weeks of age were allowed access to basal diet (CRF-1, Oriental Yeast Co., Tokyo, Japan) and water ad libitum and housed in polycarbonate cages with white wood chips for bedding in an air-conditioned room (24 ± 1 • C, 55 ± 5% relative humidity, 12 hour light and dark cycle). N-bis(2-hydroxypropyl)nitrosamine (DHPN) and sulfadimethoxine (SDM) were obtained from Nacalai Tesque Inc. (Kyoto, Japan) and Sigma Chemical Co. (St. Louis, MO), respectively. The experimental schedule is outlined in Figure 1 . Animals in experimental group 1 were initiated with a single subcutaneous DHPN injection at 2800 mg/kg body weight in saline. Group 2 animals received saline alone. One week after initiation, drinking water containing 0.1% SDM was provided ad libitum to rats in groups 1 and 2 for 0 to 10 weeks, and 4 and 10 weeks, respectively. Five rats from group 1 at weeks 0, 1, 2, 3, 6, and 8 and group 2 at weeks 4 and 10, and 10 animals from group 1 at weeks 4 and 10 were euthanized under ether anesthesia for collection of thyroid samples. Additionally, 5 rats of group 3 as a control without DHPN or SDM treatment were killed at week 4 for normal sample collection. The experiments were carried out in accordance with the Guide for Animal Experimentation in the National Institute of Health Sciences of Japan.
Histopathological Observations
The bilateral thyroid lobes were excised, weighed and fixed in ice-cold phosphate-buffered 4% paraformaldehyde and routinely embedded in paraffin. Serial tissue sections of the largest cut surface were prepared for staining with hematoxylin and eosin (H&E) and immunohistochemistry. Focal proliferative lesions of follicular epithelial cells were classified in H&E-stained sections as focal hyperplasias, adenomas, intrathyroidal carcinomas, and invasive carcinomas to the thyroid capsule or adjacent tissues according to the published criteria (Hardisty and Boorman, 1990) . Immunohistochemical Staining β-catenin and E-cadherin monoclonal antibodies against the C-terminal region of each protein were purchased from BD Tranduction Laboratories (clones 14 and 36, respectively; Lexington, KY). Anti-rat CD45R (clone HIS24) antibody for B-cell surface antigen was purchased (BD PharMingen, San Diego, CA), along with an ED1 monoclonal antibody (clone ED1; Serotec Ltd., Oxford, UK) for rat tissue macrophages, and a monoclonal antibody for Ki-67 antigen (clone MIB-5; DAKO A/S, Glostrup, Denmark) for determination of cell proliferative activities. Antigen retrieval was performed in an autoclave for 15 minutes at 121 • C in 10 mM citrate buffer (pH 6.0) for all except ED1. The streptavidin-biotin-peroxidase complex method (Hsu et al., 1981 ; StreptABComplex/HRP, DAKO) was used to determine the expression and localization of each antigen, and sections were lightly counterstained with hematoxylin for microscopic examination. Negative controls without primary antibody reactions were set for each antigen using serial sections. Ki-67-positive nuclei per up to 1,000 cells of each type of randomly selected follicular epithelial lesion were counted.
Statistical Analysis
Statistical analysis to compare the Ki-67 positivity among the lesions was carried out using the Student's t-test or Welch's t-test following the F test. Significance was inferred at the 5%, 1%, and 0.1% levels.
RESULTS
Thyroid Weights
Thyroid weights relative to body weights progressively increased from weeks 1 to 10 in both DHPN-SDM and SDM alone groups (Figure 2) , reflecting goiter and partly tumor development. 
Histopathological Observations
Control group: Follicles containing various amounts of colloid and lined by cuboidal epitheliums were observed as normal appearances in all rats (Figure 3a ). DHPN-SDM-treated group: Diffuse follicular cell hyperplasia, which was characterized by small follicles containing no or only small amounts of colloid and lined by tall columnar follicular cells, appeared at weeks 1 to 2 in all rats, with gradual recovery thereafter. Focal follicular cell hyperplasias, which were defined as well-demarcated focal lesions mostly consisting of multifollicular structures with increased cellularity, arose in thyroid parenchyma from week 3 in all rats. Multiple focal follicular cell hyperplasias and adenomas developed in parenchyma at weeks 4-6. Adenomas were defined as expansive lesions showing minor atypia, consisting of a combination of follicular, papillary, or solid structures.
Regarding the capsule, although no significant abnormality was detected in any rat by week 3, slight to severe thickening with mononuclear cell inflammation, mainly consisting of ED1-positive macrophages with slight fibrous reactions, were observed in most rats at weeks 4-6. In the inflammatory cells, some CD45R-positive B-lymphocytes were sometimes mixed. Migration of isolated follicular epithelium, showing spindle, polygonal or pseudo-follicular shapes, into the capsule was also noted at weeks 4-6. Although such migration was apparently separate from focal hyperplasias/adenomas, the migrating epithelial cells showed slight nuclear atypia. Some focal hyperplasias/adenomas adjacent to the capsule progressively developed to invasive carcinomas from weeks 6-10. At an incipient stage, invasion of some atypical cells was found in capsule-adjacent regions (Figure 4a ). Invasive or intrathyroidal lesions, characterized by atypical neoplastic cells having large nuclei with prominent nucleoli and mixtures of microfollicular and solid patterns, were defined as carcinomas. Most invasive carcinomas in the capsule or extrathyroidal adjacent tissues grew with extracellular matrix formation, sometimes without any fibrous thickening of the capsular layer ( Figure 5a ).
Near invasion fronts, mononuclear cell infiltration was persistently found accompanying invasive carcinoma growth. Invasive carcinomas were observed in all DHPN-SDM-treated rats at week 10, whereas intrathyroidal carcinomas were seldom observed. Multiplicities of focal proliferative lesions from weeks 2 to 10 counted on H&E staining sections are summarized in Figure 6 . Around the capsule, at weeks 8-10, inflammatory change had almost disappeared although significant thickening of the capsular layer, with tight connective tissue and fibroblasts, was detected in all rats. At that time, active cellar migration had also almost closed, with pockets of residual insular follicular tissue being observed in the fibrously thickened capsular layer. Some intracapsular residual follicular tissues showed minor nuclear atypia.
SDM-treatment alone group: Although no focal proliferative lesions were observed, diffuse follicular cell hyperplasia, capsular thickening with inflammatory cells (Figures 7a-7c ) and epithelial migration into the capsule (Figure 8a) , essentially similar to those in the DHPN-SDM-treated group, were frequently noted at week 4. At week 10, intracapsular residual follicular tissues with or without epithelial minor nuclear atypia in the fibrously thickened capsular layer were also observed in this group (Figure 9a ).
Immunohistochemical Analysis of β-catenin and E-cadherin Expression
Immunohistochemistry for β-catenin and E-cadherin was performed on all rat thyroids of DHPN-SDM-treated and SDM-treatment alone rats at weeks 4-10 and normal thyroid samples from control rats. Both β-catenin and E-cadherin were present at the membranes except for luminal surfaces in normal follicular epithelial cells (Figure 3b) .
In contrast, diffuse proliferative, focal proliferative, and migrated follicular cells into the capsule showed variously altered staining patterns. Cytoplasmic granular staining in the paranuclear basal portion was obviously detected in diffuse hyperplastic follicular cells for both β-catenin and E-cadherin. Migrated follicular cells as well as residual cells in the intracapsular follicular tissues frequently showed diffuse cytoplasmic/nuclear staining for β-catenin in cases with slight or minor nuclear atypia (Figures 8b, 9b) ; however, those without nuclear atypia had staining restricted to the membranes for β-catenin in both DHPN-SDM and SDM alone groups. Immunoreactivity for E-cadherin was lacking in isolated migrating follicular cells, but membranous expression was observed in the intracapsular residual follicular tissues.
In focal hyperplasias and adenomas of the DHPN-SDMtreated group, granular staining in the basal cytoplasm as in diffuse hyperplastic follicular cells, or staining restricted to the membranes as in normal follicular cells, was observed for β-catenin and E-cadherin. In carcinoma cells as well as incipient invasive cells arising in regions of focal hyperplasia/adenoma adjacent to the capsule, diffuse cytoplasmic/nuclear positivity for β-catenin was frequently observed (Figures 4b, 5b ). The staining pattern for E-cadherin in carcinoma cells was almost normal, but sometimes cytoplasmic staining was observed. In invasion fronts, immunoreactivity for E-cadherin was lacking in isolated carcinoma cells (data not shown). No significant differences in staining pattern for either β-catenin and E-cadherin were observed between invasive and intrathyroidal carcinomas.
Analysis of Ki-67 Positivity for Cell Proliferative Activity in the Lesions
Immunohistochemistry for Ki-67 revealed that epithelial cells migrated into capsules with diffuse cytoplasmic/nuclear β-catenin positivity in DHPN-SDM-treated, and SDMtreatment alone rats had increased cell proliferative activity as compared with non-proliferative parenchyma (Figures 3c,  8c ). Incipient invasive cells in capsular adjacent regions of focal hyperplasia/adenoma and invasive and intrathyroidal carcinoma cells in DHPN-SDM-treated rats generally showed significantly increased Ki-67 positivity as compared with focal hyperplasias/adenomas (Figures 4c, 5c ). Ki-67 labeling indices with reference to cytoplasmic/nuclear staining for β-catenin using serial sections at week 10 are summarized in Table 1 . Although low Ki-67 labeling levels, as in nonproliferative parenchymal cells, were found for intracapsular residual follicles with membrane-restricted β-catenin staining, significantly ( p < 0.01) elevated values were associated with diffuse cytoplasmic/nuclear β-catenin positivity ( Figure 9c ). The mean Ki-67-positive value for intracapsular residual follicles showing diffuse cytoplasmic/nuclear positivity for β-catenin was significantly ( p < 0.01) lower than that of carcinomas, whereas it was significantly ( p < 0.05) higher than that of adenomas.
DISCUSSION
It has been reported that numerous chemicals, so called goitrogens, can induce or promote the development of thyroid tumors, including invasive carcinomas to the capsule or extrathyroidal tissues, in rats. The major mechanism is considered to be thyroidal growth stimulation through serum TSH elevation. Although tumors associated with various goitrogens are indistinguishable from each other, invasive lesions are known to be particularly frequent only with certain goitrogens (Kitahori et al., 1984; Mitsumori et al., 1995; Tsuda, 1996) .
To clarify mechanisms of the progression process to invasive carcinomas, we have sequentially evaluated histopathological and immunohistochemical characteristics of thyroids in rats initiated with DHPN followed by SDM treatment. The most striking finding was the capsular thickening with inflammatory cells, mainly macrophages, and migration of isolated follicular cells into the capsule in association with early stages of SDM-induced goiter. Such changes were observed not only in the DHPN-SDM-treated rats but also with SDM alone. Although goitrogens induce invasive carcinomas at relatively higher incidence within a short period in the present 2-stage rat thyroid carcinogenesis model, they usually need much longer periods to induce carcinomas when given alone (Hiasa et al., 1987) . Therefore, the migrated cells should be distinguished from invasive carcinomas. On the other hand, some examples, and the consequent intracapsular residual follicles, exhibited weak nuclear atypia and greater cell proliferative than adenomas. Thus, further study is needed to clarify the fate of these active intracapsular residual follicles. The well-established role of β-catenin/E-cadherin is as components of cell-cell adherence junctions (Pötter et al., 1999) . The other role of β-catenin, independent of cellcell adhesive function, is as a member of the Wnt signaling pathway (Resnik, 1997) . Recent analyses have demonstrated that activation of Wnt-APC-β-catenin-T-cell factor (Tcf)/lymphoid enhancer factor (Lef) signaling contributes to genesis, not only of a variety of human tumors-i.e., colon tumors (Morin et al., 1997) and melanomas (Rubinfeld et al., 1997; Omholt et al., 2001 )-but also colon (Dashwood et al., 1998; Takahashi et al., 1998; Suzui et al., 1999) or lung tumors (Tsujiuchi et al., 2000) in some animal models.
The activation has been reported to be due to mutations of either APC or β-catenin (ctnnb1) genes (Morin et al., 1997; Rubinfeld et al., 1997; Dashwood et al., 1998; Tsujiuchi et al., 2000) . Particularly in rat colon carcinogenesis models, mutations in the β-catenin gene are frequently detectable (Dashwood et al., 1998; Takahashi et al., 1998; Suzui et al., 1999) . Immunohistochemistry for β-catenin has revealed altered expression corresponding to activation in both human and animal tumors, in terms of cytoplasmic/nuclear accumulation (Takahashi et al., 1998; Tsujiuchi et al., 2000; Garcia-Rostan et al., 2001; Omholt et al., 2001) . In thyroid carcinoma cases, abnormal β-catenin immunoreactivity is reported to be associated with poor prognosis in humans (Garcia-Rostan et al., 2001) , but to our knowledge, there have been no reports concerning β-catenin expression in animal models.
To our surprise, not only carcinoma cells but also some migrated follicular cells into capsule and subsequent intracapsular residual cells frequently showed increased cell proliferative activity coincidental with altered cytoplasmic/nuclear localization of β-catenin in the present study. Although β-catenin immunoreactivity in the colon carcinoma case features distinct nuclear accumulation (Takahashi et al., 1998) , it was here found to be relatively weak and diffuse in the nucleus and cytoplasm. The β-catenin activation alone would appear noncausal for carcinoma development since it was observed in both carcinoma cells and migrated follicular cells. This is consistent with roles of other gene mutation(s), i.e., Ki-ras mutations induced by DHPN-initiation in the early stages of tumor development in this model (Kitahori et al., 1995; Kobayashi et al., 2002) .
Indeed, the action of an activated ras gene was reported not to be sufficient to attain complete malignant conversion of the thyroid in a mouse model (Santelli et al., 1993) . Therefore, it seems most likely that the role of β-catenin in this model is important for late stages of carcinogenesis. As target genes of Tcf/Lef include examples such as c-myc (He et al., 1998) and cyclin D1 (Tetsu and McCormick, 1999) , elevated cell proliferation in both the intracapsular residual follicular cells and carcinoma cells may be due at least partly to activation of β-catenin. Mutations of APC/β-catenin (ctnnb1) genes should now be analyzed.
The cause of activation of β-catenin in the present migrated and/or subsequent intracapsular residual follicular cells and carcinoma cells was not clear, although the fact that invasive carcinomas arose in the capsular region much more frequently than within the parenchyma may be indicative. Oxidative stress (Coussens and Werb, 2002) or up-regulation of Wnt (Smith et al., 1999) in the capsular inflammatory region containing macrophages might be important in this context. Indeed, recent data provide support for the concept that inflammation is a critical component of tumor progression (Coussens and Werb, 2002) . In colon carcinoma models of rodents, activated macrophages/CD4 + T-cells or fibrous tissues play a contributory role (Berg et al., 1996; Okada et al., 2000) .
In conclusion, it is suggested that β-catenin activation related to capsular inflammation plays an important role in tumor progression to invasive carcinomas partly via cell proliferative activation but is insufficient for tumor formation by itself in the DHPN-SDM-induced rat thyroid model. Further mechanistic studies are needed to clarify the relationship of capsular inflammation and mutations or transient β-catenin activation and how this relates to tumor progression.
